missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Chemicals
  4. Organic compounds
  5. Organoheterocyclic compounds
  6. Piperidines
  7. Capivasertib, MedChemExpress

Capivasertib, MedChemExpress

Product Code. 16469097
Encompass_Preferred
Change view
Click to view available options
Quantity:
5 mg
10 mg
50 mg
100 mg
Unit Size:
100mg
10mg
50mg
5mg
4 product options available for selection
Product selection table with 4 available options. Use arrow keys to navigate and Enter or Space to select.
Product Code. Quantity unitSize
16469097 5 mg 5mg
16436518 10 mg 10mg
16402617 50 mg 50mg
16456766 100 mg 100mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 4 options available.
4 options
This item is not returnable. View return policy
Product Code. 16469097 Supplier Medchem Express Supplier No. HY15431

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

MedChemExpress Capivasertib (AZD5363) is an orally active and potent pan-AKT kinase inhibitor with IC50 of 3, 7 and 7 nM for Akt1,Akt2 and Akt3, respectively.

Capivasertib (AZD5363) is an orally active and potent pan-AKT kinase inhibitor with IC50 of 3, 7 and 7 nM for Akt1,Akt2 and Akt3, respectively.

Specifications

Chemical Name or Material Capivasertib
CAS 1143532-39-1
Color Off-White
Purity Grade Notes Research
Molecular Formula C21H25ClN6O2
Quantity 5 mg
Synonym AZD5363
Solubility Information DMSO : 125 mg/mL (291.43 mM; Need ultrasonic)
SMILES O=C(C1(N)CCN(C2=C3C(NC=C3)=NC=N2)CC1)N[C@H](C4=CC=C(Cl)C=C4)CCO
Molecular Weight (g/mol) 428.92
Formula Weight 428.92
Percent Purity 95.09%
Grade Research
Physical Form Powder
For Use With (Application) Cancer-Kinase/protease
Show More Show Less

Research purposes only

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.